Preference for pharmaceutical formulation and treatment process attributes by Stewart KD, Johnston JA, Matza LS, Curtis SE, Havel HA, Sweetana SA, Gelhorn HL

Get full text

Patient-Reported Outcomes and Impact of Type 2 Diabetes: A Cross-Sectional Study in the Kingdom of Saudi Arabia by Gelhorn HL, Boye KS, Shalhoub H, Matza LS, Jordan JB, Alhammad A, Anand SB, Ekhzaimy AA, Strizek A

Get full text

Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases by Matza LS, Cong Z, Chung K, Stopeck A, Tonkin K, Brown J, Braun A, Van Brunt K, McDaniel K

Get full text

Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes by Matza LS, Boye KS, Jordan JB, Norrbacka K, Gentilella R, Tiebout AR, Browne C, Orsini Federici M, Biricolti G, Stewart KD

Get full text

Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation by Matza LS, Phillips GA, Revicki DA, Ascher-Svanum H, Malley KG, Palsgrove AC, Faries DE, Stauffer V, Kinon BJ, Awad AG, Keefe RS, Naber D

Get full text